Hepatitis C
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV), primarily spread through blood contact, such as through contaminated needles. While the initial infection may present mild or no symptoms, chronic HCV can lead to serious complications including liver cirrhosis and liver cancer.
Health Outcomes
- Accelerated Recovery in Immunocompromised Mice
- Additional Therapeutic Benefits
- Aggravated Liver Injury
- Alleviated Liver Injury
- Altered Blood Parameters
- Altered Plasma Metabolite Levels
- Asymptomatic Carrier Status
- Attenuated Hepatic Disorders
- Changed Albumin Level
- Confirmed Safety of Treatment
- Decreased IFN-γ Levels
- Decreased Immune Response to Influenza Vaccination
- Decreased Serum IgM Levels at 60 Days
- Delayed Onset of Thrombocytopenia
- Efficacy of Postbiotics in Immunocompromised Patients
- Elevated Bile Acid Levels
- Elevated Ferric Iron Levels
- Elevated Hepatic Enzyme Levels
- Elevated Serum Alanine Aminotransferase Levels
- Elevated Serum Aspartate Aminotransferase Levels
- Elevated Serum Enzyme Levels
- Elevated Serum Globulin Levels
- Elevated Total IgM Levels
- Enhanced Alkaline Phosphatase Activity
- Enhanced Antibody Secretion
- Enhanced Antioxidant Metabolism
- Enhanced Antipathogenic Activity
- Enhanced Antiviral Response
- Enhanced Cell Viability Under Oxidative Stress
- Enhanced Host Resistance
- Enhanced IFN-γ Production
- Enhanced Immune Evasion
- Enhanced Immune Function
- Enhanced Immune Resistance
- Enhanced Interferon Gamma Production
- Enhanced Liver Protection
- Enhanced Phenotypic Maturation of Dendritic Cells
- Enhanced Protection Against Infection
- Enhanced T-Cell Response
- Improved Antiviral Effect
- Improved Antiviral Immune Response
- Improved Antiviral Response
- Improved Cell Survival Rates
- Improved Cell-mediated Immunity
- Improved Child-Pugh Score
- Improved Child-Pugh Scores
- Improved Growth in Bile-Containing Medium
- Improved Hepatic Damage
- Improved Hepatic Disease
- Improved Hepatic Function
- Improved Hepatopancreas Health
- Improved Host Health
- Improved Human Health
- Improved IFN-γ Levels
- Improved Immune Cell Counts
- Improved Immune Function
- Improved Immune Response
- Improved Immune Response to Vaccination
- Improved Immune Surveillance
- Improved Immune System Modulation
- Improved Immunity Biomarkers
- Improved Immunological Biomarkers
- Improved Immunological Indices
- Improved Immunological Response
- Improved Infection Protection
- Improved Liver Antioxidant Capacity
- Improved Liver Biomarkers
- Improved Liver Disease Biomarkers
- Improved Liver Enzyme Activity
- Improved Liver Enzyme Function
- Improved Liver Function
- Improved Liver Health
- Improved Liver Histology
- Improved Liver Morphology
- Improved Liver Regeneration
- Improved Lower Limit of Detection
- Improved Organ Histology
- Improved Overall Patient Outcomes
- Improved Pathogen Clearance
- Improved Phagocytic Activity of Macrophages
- Improved Phagocytic Function
- Improved Plasma Total Protein
- Improved Protein Synthesis in Liver
- Improved Recovery in Immunocompromised Individuals
- Improved Relative Survival Rate Against Pathogen
- Improved Resistance to Chronic Infections
- Improved Resistance to Pathogenic Infection
- Improved Resistance to Viral Infections
- Improved Response Rate
- Improved Seroconversion
- Improved Specific Antibody Response
- Improved Survival Rate Following Infection
- Improved Survival Rate in Digestive Conditions
- Improved Survival Through Digestive Tract
- Improved Total Antioxidant Status
- Improved Treatment Success
- Improved Vaccine Response in Immunocompromised Hosts
- Increase in Persistent Diseased Sites
- Increased Apoptosis
- Increased Apoptosis in T Cells
- Increased Aspartate Aminotransferase Concentration
- Increased Aspartate Aminotransferase Level
- Increased Aspartate Transferase Level
- Increased Bile Resistance
- Increased CD3+CD4+IFN-γ+ T Cell Count
- Increased CD3+CD8+ Cell Counts
- Increased CD4+ and CD8+ T Cell Proportion
- Increased CD8+ T Cells
- Increased Cellular Apoptosis
- Increased Conjugated Bile Acid Levels
- Increased Degradation of Non-Assimilated Compounds
- Increased Enzyme Production
- Increased Hepatic Antioxidant Enzyme Levels
- Increased Hepatic Glutathione Levels
- Increased Histological Damage
- Increased IgM Concentration
- Increased Immunoglobulin M Levels
- Increased Interferon-Alpha Production
- Increased Liver Enzyme Levels
- Increased NK Cell Count
- Increased Need for Repeated Dosing
- Increased Plasma GLDH
- Increased Plasma Protein Levels
- Increased Protease Activity
- Increased Serum Ferritin Level
- Increased Serum IgM Levels at 30 Days
- Increased Serum Interferon Gamma Levels
- Increased Serum Peroxidase Activity
- Increased Serum Protein Levels
- Increased Serum Total Bile Acid Levels
- Increased Specific Antibody Levels
- Increased Spontaneous Remission Rate
- Increased Superoxide Dismutase Levels
- Increased Survival Against Pathogens
- Increased Survival Rates of Infected Hosts
- Increased Total Bile Acid Levels
- Increased Total Body Iron Level
- Increased Tumor Necrosis Factor-Alpha Levels
- Increased Vaccine-Specific Plasma Immunoglobulin G (IgG)
- Increased Viral Clearance Rate
- Induction of Specific CD8+ T Cells
- Liver Histopathological Damage
- Lowered Serum Levels of Liver Injury Markers
- Maintained Albumin Levels
- Maintained Normal ALT Levels
- Maintained Normal Liver Function
- Maintained Safety with Repeated Oral Exposure
- Maintained Total Protein Levels
- Maintenance of NK Cell Activity
- Modulated Immune Marker IFN-γ
- Neutralized Reactive Oxygen Species
- No Antiviral Effect
- No Change in Fibrosis
- No Cytochrome P450 Induction
- No Measurable IFN-Alpha Induction
- No Significant Change in Aflatoxin Distribution or Metabolism
- Potential Modulation of FGF-19 Levels
- Preserved Liver Function
- Preserved Liver Structure
- Prevented Increase in Total Bilirubin
- Prevented Liver Fibrosis
- Prevented Liver Injury
- Prevented Liver Pathway Dysregulation
- Protection Against Cellular Damage Induced by Pathogens
- Protection Against Pathogen Dissemination
- Reduced AFB1-Induced Liver Damage
- Reduced ALT Levels
- Reduced AST Levels
- Reduced Abnormal Increase in Bilirubin
- Reduced Acute Liver Injury
- Reduced Alanine Transaminase Levels
- Reduced Ammonia Levels
- Reduced Anticoagulation / Increased Warfarin Variability
- Reduced Apolipoprotein B Level
- Reduced Apoptosis Induced by Pathogens
- Reduced Aspartate Aminotransferase Levels
- Reduced Aspartate Transaminase Activity
- Reduced Bilirubin Levels
- Reduced Biochemical Marker Levels
- Reduced Blood Clot Formation
- Reduced Butyrylcholinesterase Activity
- Reduced Cancer Mortality
- Reduced Cell Viability
- Reduced Clonorchiasis Severity
- Reduced Cumulative Mortality from Vibrio vulnificus
- Reduced Cytotoxicity
- Reduced Disease Incidence
- Reduced Disease Progression
- Reduced Elevated Liver Enzymes
- Reduced Elevated Serum Alanine Aminotransferase (ALT)
- Reduced Fibrosis Marker Levels
- Reduced GPT Level
- Reduced Glutamyl Pyruvic Transaminase Levels
- Reduced Harmful Enzyme Activity
- Reduced Hepatic Apoptosis
- Reduced Hepatic Damage Indices
- Reduced Hepatic Glycogen Levels
- Reduced Hepatic Histological Injury
- Reduced Hepatic Inflammation
- Reduced Hepatic Inflammation Markers
- Reduced Hepatic Inflammation and Oxidative Stress
- Reduced Hepatic Inflammatory Cytokines
- Reduced Hepatic Nitric Oxide Production
- Reduced Hepatic Steatosis Severity
- Reduced Hepatocellular Carcinoma Progression
- Reduced Hepatocellular Carcinoma Recurrence
- Reduced Hepatocellular Damage
- Reduced Hepatocyte Necrosis
- Reduced Hepatocyte Oxidative Stress
- Reduced Hepatotoxicity
- Reduced Hepatotoxicity from Iron Oxide Nanoparticles
- Reduced Histological Damage
- Reduced Histological Liver Injury
- Reduced Histological Scores
- Reduced IFN-γ Levels
- Reduced Incidence of Abnormal Increase in Alkaline Phosphatase
- Reduced Incidence of Hyperbilirubinemia
- Reduced Incidence of Liver Cancer
- Reduced Interferon-Gamma Levels
- Reduced Lipopolysaccharide-Binding Protein
- Reduced Liver Biochemical Markers
- Reduced Liver Damage
- Reduced Liver Damage Indicators
- Reduced Liver Damage Markers Levels
- Reduced Liver Disease Progression
- Reduced Liver Disease Symptoms
- Reduced Liver Enzyme Activity
- Reduced Liver Fibrosis
- Reduced Liver Function
- Reduced Liver Function Indicators
- Reduced Liver Inflammation
- Reduced Liver Inflammation Fibrosis Score
- Reduced Liver Injury
- Reduced Liver Injury Indicators
- Reduced Liver Injury Marker
- Reduced Liver Lesion Severity
- Reduced Liver Oxidative Damage
- Reduced Liver Oxidative Stress Injury
- Reduced Liver Stiffness
- Reduced Liver Toxicity
- Reduced Lobular Inflammation
- Reduced M1 Macrophage Population
- Reduced Microbial Translocation to the Liver
- Reduced Mortality Rate During Pathogen Challenge
- Reduced Organ Injury
- Reduced Overall Mortality Rate
- Reduced Oxidative Stress Markers
- Reduced Pathogen Counts in Organs
- Reduced Pathogen Infection
- Reduced Pathogen Load in Visceral Organs
- Reduced Pathogen Viability
- Reduced Pathogen-Induced Weight Loss
- Reduced Pathological Changes of Liver
- Reduced Phagocytic Activity
- Reduced Plasma IgG Production
- Reduced Risk of Infection
- Reduced Risk of Pathogen Dissemination
- Reduced Serum Alanine Aminotransferase Activity
- Reduced Serum Alanine Aminotransferase Levels
- Reduced Serum D-Lactate Levels
- Reduced Serum Gamma Glutamine Transaminase Levels
- Reduced Serum Haptoglobin Concentration
- Reduced Serum Haptoglobin Levels
- Reduced Serum Transaminase Levels
- Reduced Susceptibility to Infection
- Reduced Thrombocytopenia
- Reduced Total Infections
- Reduced Toxin-induced Cytotoxicity
- Reduced Treatment Costs
- Reduced Treatment Failure
- Reduced Viral Activity
- Reduced Viral Binding
- Reduced Viral Clearance Time
- Reduced Viral Entry
- Reduced Viral Infection
- Reduced Viral Infection Incidence
- Reduced Viral Load
- Reduced Virulence of Pathogens
- Reduced Virus Titer
- Regenerated Hepatic Tissue
- Restored T-Cell Population
- Significant Histopathological Changes in Liver
- Stabilized Total Bilirubin Levels
- Stable Alanine Aminotransferase Levels
- Stable Aspartate Aminotransferase Levels
- Sustained Immune Activity
- Unchanged Monocyte Chemoattractant Protein-1 Levels
- White Blood Cell Count